Full-Time

Total Rewards Lead

Confirmed live in the last 24 hours

Genesis Therapeutics

Genesis Therapeutics

51-200 employees

AI-driven drug discovery for pharmaceuticals

AI & Machine Learning
Biotechnology

Compensation Overview

$170k - $220kAnnually

Senior, Expert

Burlingame, CA, USA

Hybrid position based in Burlingame, CA.

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Data Analysis
Requirements
  • Bachelor's degree in Human Resources, Business, or related field is required; Master's degree or relevant certifications (e.g., CCP, GRP) preferred
  • Minimum of 8 years of progressive experience in compensation, with a track record of success in scaling organizations
  • Comfortable working in a fast-paced startup environment that will require you to manage competing priorities, pivot quickly and often, and continually build new processes as the company scales, preferably in an AI Start-up environment
  • Strong understanding of compensation practices, regulations, and market trends
  • Excellent analytical and problem-solving skills, with the ability to use data to drive decision-making
  • Excellent communication and interpersonal skills, with the ability to collaborate effectively with executive leadership and employees
  • Exceptional presentation skills, ability to create and present complex data visually in a clear, concise manner across a variety of audiences
  • Detail-oriented with a high level of accuracy and time management skills
Responsibilities
  • Develop and execute a comprehensive total compensation strategy aligned with the company's objectives and values, ensuring that it supports our scale and growth plans
  • Lead the design, implementation, and maintenance of competitive compensation programs, including base pay, equity incentives, and executive compensation
  • Utilize data analytics and benchmarking to make informed decisions about compensation and benefits, regularly reviewing and adjusting programs to remain competitive
  • Provide thought leadership, and consultation to senior leaders on the development of total rewards methodologies and philosophy, including supporting policies, practices, systems and external partners
  • Supporting Compensation Committee Content: Provides analysis and creates presentation of data to be shared with the Board Compensation Committee, including relevant data analysis and recommendations
  • Stay up-to-date on industry trends, legal requirements, and market dynamics to ensure compliance and relevance of compensation programs
  • Ensure that all compensation and benefits programs comply with relevant laws and regulations, and maintain strong governance practices
  • Partner with finance, people operations, recruitment teams, and executives on pay decisions, compensation process & policies, retention strategies, and job evaluation
  • Develop communication strategies to educate both new and existing employees about their compensation

Genesis Therapeutics uses artificial intelligence to accelerate the development of new medicines in the pharmaceutical industry. By employing 3D spatial graph modeling and advanced molecular simulation, the company identifies potential drug candidates and explores new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech firms, such as Eli Lilly, to generate revenue through upfront payments and future earnings based on drug success. The company's goal is to discover new medicines that address unmet medical needs.

Company Stage

Series B

Total Funding

$272.5M

Headquarters

Burlingame, California

Founded

2019

Growth & Insights
Headcount

6 month growth

14%

1 year growth

45%

2 year growth

137%
Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with NVIDIA enhances GEMS platform for targeting diseases with high unmet needs.
  • Recognition as a 'Fierce 15' company underscores Genesis' innovative approach in drug development.
  • Recent $224M equity investment indicates strong investor confidence in Genesis' AI platform.

What critics are saying

  • Increased competition from AI-driven drug discovery companies like Insilico Medicine and Exscientia.
  • Over-reliance on partnerships could lead to financial instability if drugs aren't successful.
  • Rapid AI advancements may require costly updates to maintain competitive advantage.

What makes Genesis Therapeutics unique

  • Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.
  • The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.
  • Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program